Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s004280100438.

Title:
Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases | Virchows Archiv
Description:
Most intraductal papillary-mucinous carcinomas (IPMCs) of the pancreas are resectable and curable, but some develop into frankly invasive carcinomas. We studied the clinicopathologic features of eight cases of invasive carcinoma derived from IPMC (IC-IPMC) of the pancreas. The patients were aged 54–75 years (mean, 66.6 years); six were male and two were female. The mean tumor size was 7.7 cm (range 5.5–10.5 cm). Two patients without lymph node metastasis had no peripancreatic invasion, and survived longer (115 and 20 months). Three out of four patients with extrapancreatic invasion died of their tumors or developed tumor recurrence within a year. One patient with evidence of liver and lymph node metastasis at the time of first surgery again showed metastatic tumor 21 months later. One patient died of another cause. We also performed a comparative study of the immunohistochemical features of IC-IPMCs in 9 IPMCs (including minimally invasive cases) and 15 ductal adenocarcinomas. CEA cytoplasmic positivity was observed in most of the IC-IPMCs (87.5%) and ductal adenocarcinomas (93.3%), but in only 1 IPMC (11.1%) . The frequency of p53 nuclear staining in ductal adenocarcinoma (73.3%) was higher than in IPMC (33.3%) or IC-IPMC (37.5%). In conclusion, IC-IPMC with extrapancreatic invasion should be treated as ductal carcinoma because of its aggressive behavior after resection. Some IPMCs might progress to invasive carcinoma via pathways that are different from those followed by ductal adenocarcinomas.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Animals & Wildlife
  • Telecommunications
  • Mobile Technology & AI

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

article, carcinoma, japan, invasive, cancer, intraductal, pancreas, access, center, privacy, cookies, content, research, ductal, division, national, information, publish, search, papillarymucinous, cases, open, data, log, journal, virchows, derived, clinicopathologic, immunohistochemical, study, fukushima, mukai, sakamoto, ipmcs, ipmc, icipmc, patients, tumor, invasion, surgery, adenocarcinomas, resection, pancreatic, papillary, mucinous, discover, pathology, hospital, tokyo, springer,

Topics {✒️}

intraductal papillary-mucinous carcinoma intraductal papillary-mucinous carcinomas month download article/chapter invasive carcinoma derived related subjects pancreatic resection kazuaki shimada tomoo kosuge frankly invasive carcinomas full article pdf invasive carcinoma privacy choices/manage cookies michiie sakamoto article fukushima european economic area takahiro hasebe lymph node metastasis developed tumor recurrence cea cytoplasmic positivity p53 nuclear staining ductal adenocarcinoma check access instant access remnant pancreas recurrence conditions privacy policy ductal carcinoma accepting optional cookies kiyoshi mukai article log extrapancreatic invasion died journal finder publish virchows arch 439 surgery article cite information year privacy policy personal data books a optional cookies manage preferences tumor size extrapancreatic invasion subscription content similar content pancreas focusing data protection essential cookies cookies skip japan

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases
         description: Most intraductal papillary-mucinous carcinomas (IPMCs) of the pancreas are resectable and curable, but some develop into frankly invasive carcinomas. We studied the clinicopathologic features of eight cases of invasive carcinoma derived from IPMC (IC-IPMC) of the pancreas. The patients were aged 54–75 years (mean, 66.6 years); six were male and two were female. The mean tumor size was 7.7 cm (range 5.5–10.5 cm). Two patients without lymph node metastasis had no peripancreatic invasion, and survived longer (115 and 20 months). Three out of four patients with extrapancreatic invasion died of their tumors or developed tumor recurrence within a year. One patient with evidence of liver and lymph node metastasis at the time of first surgery again showed metastatic tumor 21 months later. One patient died of another cause. We also performed a comparative study of the immunohistochemical features of IC-IPMCs in 9 IPMCs (including minimally invasive cases) and 15 ductal adenocarcinomas. CEA cytoplasmic positivity was observed in most of the IC-IPMCs (87.5%) and ductal adenocarcinomas (93.3%), but in only 1 IPMC (11.1%) . The frequency of p53 nuclear staining in ductal adenocarcinoma (73.3%) was higher than in IPMC (33.3%) or IC-IPMC (37.5%). In conclusion, IC-IPMC with extrapancreatic invasion should be treated as ductal carcinoma because of its aggressive behavior after resection. Some IPMCs might progress to invasive carcinoma via pathways that are different from those followed by ductal adenocarcinomas.
         datePublished:2001-03-31T00:00:00Z
         dateModified:2001-03-31T00:00:00Z
         pageStart:6
         pageEnd:13
         sameAs:https://doi.org/10.1007/s004280100438
         keywords:
            Intraductal papillary-mucinous carcinoma Pancreas Invasive carcinoma Immunohistochemistry
            Pathology
         image:
         isPartOf:
            name:Virchows Archiv
            issn:
               1432-2307
               0945-6317
            volumeNumber:439
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Noriyoshi Fukushima
               affiliation:
                     name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan
                     address:
                        name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kiyoshi Mukai
               affiliation:
                     name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
                     address:
                        name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michiie Sakamoto
               affiliation:
                     name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
                     address:
                        name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Takahiro Hasebe
               affiliation:
                     name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
                     address:
                        name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kazuaki Shimada
               affiliation:
                     name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
                     address:
                        name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tomoo Kosuge
               affiliation:
                     name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
                     address:
                        name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Taira Kinoshita
               affiliation:
                     name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan
                     address:
                        name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Setsuo Hirohashi
               affiliation:
                     name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
                     address:
                        name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases
      description: Most intraductal papillary-mucinous carcinomas (IPMCs) of the pancreas are resectable and curable, but some develop into frankly invasive carcinomas. We studied the clinicopathologic features of eight cases of invasive carcinoma derived from IPMC (IC-IPMC) of the pancreas. The patients were aged 54–75 years (mean, 66.6 years); six were male and two were female. The mean tumor size was 7.7 cm (range 5.5–10.5 cm). Two patients without lymph node metastasis had no peripancreatic invasion, and survived longer (115 and 20 months). Three out of four patients with extrapancreatic invasion died of their tumors or developed tumor recurrence within a year. One patient with evidence of liver and lymph node metastasis at the time of first surgery again showed metastatic tumor 21 months later. One patient died of another cause. We also performed a comparative study of the immunohistochemical features of IC-IPMCs in 9 IPMCs (including minimally invasive cases) and 15 ductal adenocarcinomas. CEA cytoplasmic positivity was observed in most of the IC-IPMCs (87.5%) and ductal adenocarcinomas (93.3%), but in only 1 IPMC (11.1%) . The frequency of p53 nuclear staining in ductal adenocarcinoma (73.3%) was higher than in IPMC (33.3%) or IC-IPMC (37.5%). In conclusion, IC-IPMC with extrapancreatic invasion should be treated as ductal carcinoma because of its aggressive behavior after resection. Some IPMCs might progress to invasive carcinoma via pathways that are different from those followed by ductal adenocarcinomas.
      datePublished:2001-03-31T00:00:00Z
      dateModified:2001-03-31T00:00:00Z
      pageStart:6
      pageEnd:13
      sameAs:https://doi.org/10.1007/s004280100438
      keywords:
         Intraductal papillary-mucinous carcinoma Pancreas Invasive carcinoma Immunohistochemistry
         Pathology
      image:
      isPartOf:
         name:Virchows Archiv
         issn:
            1432-2307
            0945-6317
         volumeNumber:439
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Noriyoshi Fukushima
            affiliation:
                  name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan
                  address:
                     name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kiyoshi Mukai
            affiliation:
                  name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
                  address:
                     name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michiie Sakamoto
            affiliation:
                  name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
                  address:
                     name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Takahiro Hasebe
            affiliation:
                  name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
                  address:
                     name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kazuaki Shimada
            affiliation:
                  name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
                  address:
                     name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tomoo Kosuge
            affiliation:
                  name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
                  address:
                     name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Taira Kinoshita
            affiliation:
                  name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan
                  address:
                     name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Setsuo Hirohashi
            affiliation:
                  name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
                  address:
                     name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Virchows Archiv
      issn:
         1432-2307
         0945-6317
      volumeNumber:439
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan
      address:
         name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan, Japan
         type:PostalAddress
      name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
      address:
         name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
         type:PostalAddress
      name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
      address:
         name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
         type:PostalAddress
      name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
      address:
         name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
         type:PostalAddress
      name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
      address:
         name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
         type:PostalAddress
      name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
      address:
         name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
         type:PostalAddress
      name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan
      address:
         name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan, Japan
         type:PostalAddress
      name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
      address:
         name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Noriyoshi Fukushima
      affiliation:
            name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan
            address:
               name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan, Japan
               type:PostalAddress
            type:Organization
      name:Kiyoshi Mukai
      affiliation:
            name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
            address:
               name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
               type:PostalAddress
            type:Organization
      name:Michiie Sakamoto
      affiliation:
            name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
            address:
               name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
               type:PostalAddress
            type:Organization
      name:Takahiro Hasebe
      affiliation:
            name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan
            address:
               name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
               type:PostalAddress
            type:Organization
      name:Kazuaki Shimada
      affiliation:
            name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
            address:
               name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
               type:PostalAddress
            type:Organization
      name:Tomoo Kosuge
      affiliation:
            name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan
            address:
               name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
               type:PostalAddress
            type:Organization
      name:Taira Kinoshita
      affiliation:
            name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan
            address:
               name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan, Japan
               type:PostalAddress
            type:Organization
      name:Setsuo Hirohashi
      affiliation:
            name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
            address:
               name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Clinical Laboratory Division, National Cancer Center Hospital, 5–1-1 Tsukiji, Chuo-ku, Tokyo 104–0045, Japan, Japan
      name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
      name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
      name:Pathology Division, National Cancer Center Research Institute East, Kashiwa, Japan, Japan
      name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
      name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan, Japan
      name:Hepato-biliary-pancreatic Surgery Division, National Cancer Center Hospital, East, Kashiwa, Japan, Japan
      name:Pathology Division, National Cancer Center Research Institute, Tokyo, Japan, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(39)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

3.5s.